These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8752212)

  • 1. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism.
    Mohammadi M; Schlessinger J; Hubbard SR
    Cell; 1996 Aug; 86(4):577-87. PubMed ID: 8752212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis.
    McTigue MA; Wickersham JA; Pinko C; Showalter RE; Parast CV; Tempczyk-Russell A; Gehring MR; Mroczkowski B; Kan CC; Villafranca JE; Appelt K
    Structure; 1999 Mar; 7(3):319-30. PubMed ID: 10368301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.
    Mohammadi M; Froum S; Hamby JM; Schroeder MC; Panek RL; Lu GH; Eliseenkova AV; Green D; Schlessinger J; Hubbard SR
    EMBO J; 1998 Oct; 17(20):5896-904. PubMed ID: 9774334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
    Pellegrini L; Burke DF; von Delft F; Mulloy B; Blundell TL
    Nature; 2000 Oct; 407(6807):1029-34. PubMed ID: 11069186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region.
    Wybenga-Groot LE; Baskin B; Ong SH; Tong J; Pawson T; Sicheri F
    Cell; 2001 Sep; 106(6):745-57. PubMed ID: 11572780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
    Ibrahimi OA; Eliseenkova AV; Plotnikov AN; Yu K; Ornitz DM; Mohammadi M
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7182-7. PubMed ID: 11390973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.
    Mohammadi M; McMahon G; Sun L; Tang C; Hirth P; Yeh BK; Hubbard SR; Schlessinger J
    Science; 1997 May; 276(5314):955-60. PubMed ID: 9139660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for FGF receptor dimerization and activation.
    Plotnikov AN; Schlessinger J; Hubbard SR; Mohammadi M
    Cell; 1999 Sep; 98(5):641-50. PubMed ID: 10490103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase.
    Klingbeil CK; Gill GN
    Arch Biochem Biophys; 1999 Mar; 363(1):27-32. PubMed ID: 10049496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural interactions of fibroblast growth factor receptor with its ligands.
    Stauber DJ; DiGabriele AD; Hendrickson WA
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):49-54. PubMed ID: 10618369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor (cFMS) in complex with two inhibitors.
    Schubert C; Schalk-Hihi C; Struble GT; Ma HC; Petrounia IP; Brandt B; Deckman IC; Patch RJ; Player MR; Spurlino JC; Springer BA
    J Biol Chem; 2007 Feb; 282(6):4094-101. PubMed ID: 17132624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an autoinhibitory domain in the insulin receptor tyrosine kinase.
    Filipek A; Soderling TR
    Mol Cell Biochem; 1993 Mar; 120(2):103-10. PubMed ID: 8487750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of FGF receptors by mutations in the transmembrane domain.
    Li Y; Mangasarian K; Mansukhani A; Basilico C
    Oncogene; 1997 Mar; 14(12):1397-406. PubMed ID: 9136983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.
    Hubbard SR
    EMBO J; 1997 Sep; 16(18):5572-81. PubMed ID: 9312016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the tyrosine kinase domain of the human insulin receptor.
    Hubbard SR; Wei L; Ellis L; Hendrickson WA
    Nature; 1994 Dec 22-29; 372(6508):746-54. PubMed ID: 7997262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tyrosines 154 and 307 in the extracellular domain and 653 and 766 in the intracellular domain as phosphorylation sites in the heparin-binding fibroblast growth factor receptor tyrosine kinase (flg).
    Hou J; McKeehan K; Kan M; Carr SA; Huddleston MJ; Crabb JW; McKeehan WL
    Protein Sci; 1993 Jan; 2(1):86-92. PubMed ID: 8443592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail.
    Shewchuk LM; Hassell AM; Ellis B; Holmes WD; Davis R; Horne EL; Kadwell SH; McKee DD; Moore JT
    Structure; 2000 Nov; 8(11):1105-13. PubMed ID: 11080633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction. Autoinhibition control.
    Schlessinger J
    Science; 2003 May; 300(5620):750-2. PubMed ID: 12730587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.